chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician assistant concerning a 59 year old female with high blood pressure, high cholesterol, unidentified allergies, RAYNAUD'S disease and many unspecified drug allergies who on 07-JUL-2008 was vaccinated with a dose of ZOSTAVAX (LOT# 657675/0618U). Concomitant therapy included hydrochlorothiazide (manufacturer unknown), verapamil,
This spontaneous report as received from a health care worker refers to unspecified patients of unknown demographics. The pertinent medical history and concomitant medication were not reported. On an unknown date the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # K005177, expiry: 10-APR-2016; lot # L004654, Expiry: 11-FEB-2017; Lot #K009758, Expiry: 08-JUL-2016)(number of doses unspecified). No adverse effects were reported. The reporter inquired about the temperature excursions. The is one of the several reports received from the same reporter. Additional information has been requested.
The second day after vaccines, patient stopped responding to sounds. Within a week she stopped talking. She was irritable, but showed no other signs of being unwell. On July 22, 2016 I took her to the clinic she was being seen at as things were not improving. There is was brushed off by the physician being told "vaccines don't cause autism". She did not address my daughter not responding to sounds or no longer talking so we took her to the ER. There she started running a fever of 104.5 degrees Fahrenheit. We were sent home with a diagnosis of a virus and still no answers as to why my daughter was no longer talking or responding to sound. I went back to her clinic and saw a different practitioner a few weeks later to request an ENT referral. November 3, 2016 patient saw the ENT and failed the booth test. The doctor saw fluid on her ears and suggested tubes and hoped that would help. December 1, 2016 her tubes were placed but did not help. We were then sent to see about hearing aids. At this new clinic, patient passed the ear tests but once again failed the booth test. They now believed she had auditory neuropathy and sent her for an ABR. A sedated ABR was performed on February 17, 2017. Patient passed this with flying colors. We are still trying to find out what happened with our daughter. She has an appointment next month.
Baby was administered vaccines as below. Baby was 2 weeks of age at administration. Baby's parent given information sheets for each of vaccines given. Prescription for infant Tylenol drops with instructions-if fever above 100.4 or pain give .4ml every 4-6 hours. Patient not evaluated by CPNP. After incident parent refused care at this facility didn't want child seen here.
On 12/25/2021, I was admitted to the hospital with pneumonia and sepsis
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 07-DEC-2015, the patient was vaccinated with dose of an improperly stored ZOSTAVAX injection, subcutaneously, lot # reported as L032399, expiration date: 26-NOV-2016 (exact dose was not reported). Concomitant medications were not provided. There was no adverse effect reported. Additional information has been requested.
Patient received flu vaccine on 12-16-15 at a well child 9 month check. Patient had no preexisting conditions, no adverse reaction. Patient died on 12-18-15 from unknown causes pending autopsy/coroner report. No adverse reaction occurred prior to death.
This spontaneous prospective pregnancy report was received from a consumer regarding an approximately 25 year old female patient. The patient had no pertinent medical history or drug reactions/allergies. On 22-OCT-2015, the patient was vaccinated with GARDASIL 9 (lot#, expiration date and dosing details unknown) intramuscular for prophylaxis. At the time of the report, she was now 6 week's pregnant (Drug exposure before pregnancy). Her last menstrual period was approximately on 10-NOV-2016 and Estimated due date is 17-AUG-2017. The outcome of pregnancy was pending. The patient did not receive any treatment and did not sought medical attention for the event. It was reported that the patient did not discontinue the suspect therapy. Additional information has been requested.
After first dose of moderna was administered patient got up to sit in waiting area. She began to complain of not being able to see and said that she could only see black. She then said that she could not hear anything. She became sweaty and felt faint. We had her lie down and called 911. She got better by the time EMS arrived and was not transported to the hospital.
A couple of days after my vaccination, I had itchiness that became red spots and tingling and numbness on my abdomen and leg; my brother that's a practitioner informed me it might be shingles. So to confirm it, I went to see my doctor who confirmed it was shingles. She prescribed me an anti-viral medication (Valtrex). The symptoms lasted for about two weeks after using the medication, but wasn't as excruciating and itchy anymore.
The plaintiff recv vax in JUL93 w/DTP vax/HIBTiter & Orimune;the plaintiff alleges that devel spastic paraparesis in lower extremities;
Tdap was given when it was not due. Was supposed to be given Meningitis B. No adverse symptoms to Tdap. Dad was called and Pt is scheduled to receive correct vaccine at upcoming appt.1
Feel an armpit swollen lymph lump; Body warmer than usual; Injection site pain; This is a spontaneous report from a non-contactable consumer reporting for herself. This is the second of two reports. A 52-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot En6201, via an unspecified route of administration in left arm on 23Feb2021 13:40 (at the age of 52 years) at single dose for covid-19 immunisation. The patient previously received the first dose of bnt162b2, Lot En9264, via an unspecified route of administration in left arm on 02Feb2021 13:30 (at the age of 52 years) at single dose for covid-19 immunisation and experienced injection site pain for 1 day. Medical history included high blood pressure.  The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. Allergies to medications, food, or other products were none. Concomitant medication included losartan, vitamin d3, ubidecarenone (Q10).  The patient experienced injection site pain on 23Feb2021, body warmer than usual on 24Feb2021, feel an armpit swollen lymph lump on 25Feb2021. Laboratory data included body temperature 37.3C on 24Feb2021, and normal on 25Feb2021. No treatment was received for the events. The events were non serious with outcome unknown.   No follow-up attempts are possible. No further information is expected.
Hospitalization for acute respiratory failure due to COVID-19on dates 1/9/23- 1/19/23. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 17-SEP-2012, the patient was vaccinated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 13-OCT-2016, the patient was treated by a physician for the onset of a severe vesicular eruption accompanied by weakened immune symptoms, which was diagnosed as herpes zoster or shingles. The patient has been prescribed acyclovir for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Listlessness, exhaustion, and shortness of breath upon exertion (more than normal) lead to a cardiologist referral from GP. 2/24/22- Cardiologist diagnosed Pericarditis from EKG No treatments as of yet, monitoring pericarditis to see if it resolves itself without medical intervention.
Loose stools; Swelling in the arm; Soreness of the arm; Body aches; Fatigue; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stools), PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Soreness of the arm), PAIN (Body aches) and FATIGUE (Fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction. Concomitant products included SIMVASTATIN, CLONAZEPAM, RALOXIFENE HYDROCHLORIDE (EVISTA), FINASTERIDE and LOTEPREDNOL ETABONATE (LOTREL [LOTEPREDNOL ETABONATE]) for an unknown indication.   On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Soreness of the arm), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). On 05-Apr-2021, the patient experienced DIARRHOEA (Loose stools). On 30-Mar-2021, PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Soreness of the arm), PAIN (Body aches), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (Loose stools) outcome was unknown.            Treatment includes Ibuprofen, Lomotil The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was unknown For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route), the reporter did not provide any causality assessments.
Fever of 100-101; A spontaneous report was received from a female consumer name and age unknown who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a fever of 100-101.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 29 Dec 2020, approximately one day prior to the onset of the event, the patient received her first of two planned doses of mRNA-1273  intramuscularly for prophylaxis of COVID-19 infection.   On 30 Dec 2020, the patient called to report that she is having a fever of 100-101 and asked what temperatures she should be concerned about.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, fever of 100-101, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Ran fever and felt bad with the first injection...but about 24 hours after the 2nd in the series I developed a fever of 103.2..injection site looks good..slightly tender but no redness, swelling etc.
11Sep89 pt vax w/ hepta B; exp feeling of body warmth, facial swelling, tiredness, hives, + rash over body.  Tx w/ med.
ringing in ears/tinnitus; they did it wrong, states that she had bruising because the person giving it to her was standing instead of sitting; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unknown route at deltoid right on 19Feb2021 at 13:20 (lot number: EN6201) (age at vaccination 49-year-old) as dose 2, single for COVID-19 immunisation in hospital. The patient medical history included non-alcoholic fatty liver, obesity, restless leg syndrome, arthritis, chronic ear infections (as a kid), scarring, two sets of tubes put in and once a ruptured ear drum from an unknown date and ongoing. The patient received flu vaccine on 08Jan2021 within four weeks prior to the first administration date of the suspect vaccine. List all vaccines administered on same date with the Pfizer vaccine considered as suspect was reported as none. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unknown route at arm right on 22Jan2021 around 09:00 in the morning (lot number: EL8982) (age at vaccination 49-year-old) as dose 1, single for COVID-19 immunisation. The patient concomitant medications included for mirapex for restless leg syndrome since years and voltaren for arthritis maybe from 4 months ago. The patient family medical history relevant to adverse events and relevant tests was none. The patient had experienced ringing in ears/tinnitus and they did it wrong, states that she had bruising because the person giving it to her was standing instead of sitting. The patient did not required to attend the physician office and emergency room. Treatment received was reported as none. The outcome of the event ringing in ears/tinnitus was not recovered and the event bruising was recovered on an unknown date.  No follow-up attempts are possible. No further information is expected.
No known adverse effects; patient received a dose of M-M-R II via the intramuscular route in error; This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On 03-MAY-2019 the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, frequency were not reported) (lot # R030812, expiry date: 24-OCT-2020) via intramuscular route in error for prophylaxis (incorrect route of product administration). Other suspect therapies included sterile diluent(STERILE DILUENT) (dose, frequency were not reported) (lot # S005008, expiry date: 27-SEP-2021). No adverse effect was reported. No product quality complaint was involved.
pt stated that p/vax arm began to itch;also stated it was extremely sore w/neck & shoulder also hurting;inj site was red, swollen, & warm to touch;signs & sx cont on Saturday;pt states is better now;
Pt received Pneumovax 14-DEC-2001 at 1100. By 2000 hours 14-DEC-2001, large red welt and pain in arm. Seen 17-DEC-2001, erythema 14 mm in diameter.
Client called today to report events that happened after vaccine yesterday. Client self reported itching started approximately one hour after vaccine and beginning in the lips and face. Client then stated, "the itching moved down the body." Client reported itching from head to toe. Client reported taking Benadryl 25 mg about two hours after vaccine and did report it helped lessen the severity of the itching. Itching came back before bed and client took another Benadryl. Client experiencing itching still this morning and reported taking another Benadryl to relieve symptoms. Advised to call provider for guidance after phone call and go be seen immediately if any difficulty breathing or worsening of symptoms.
S:  Pt is here with chief complaint of rash-present for the past 2 days, this is day # 3, reports it started the next day after starting the ranitidine, he reports he didn't get it right away, and was taking the naproxen without any stomach problems but started the ranitidine as ordered and placed in his med box, and now doesn't know which pill.  The rash has gotten worse each day, is on all of body "except his toe nails", and he laughs. Allergies:  POLYESTER From PA note 1/27/10 after multiple visits to PA and NP plus consult to dermatologist. Ranitidine was ruled out. Zostavax was never ruled as a cause.  This is only coincidence that this submitter felt needed to be reported. "After admission, on approximately 12/26/09, he developed symptoms of pruritis and appearance of pink papular rash which quickly became more confluent. This was first called to attention of this provider on 12/29/09. This was initially thought to be possible atopic reaction to oral ranitidine which was discontinued. Veteran verifies he wears only 100% cotton clothes/underwear due to his allergy to polyester. He had no constitutional symptoms of fever, nausea, vomiting, diarrhea, vital signs remained normal. At one point at least 2 weeks later, he reported "my throat might have been sore for a day or two." He was put on an oral prednisone taper. Over the years, he had had similar episodes of "unexplained rashes" and was even seen in dermatology MD in 2007. No distinct etiology was ever found for his intermittent outbreaks of "red skin and itch". The syndrome was called "erythroderma" by dermatologist. Records were  scanned. In early January, his rash progressed to involve most of his trunk and extremities, neck and lower check. He never had swelling or intra/extraoral involvement. By this time, all of his oral medications except prednisone and doxepin to help pruritis at night had been discontinued. He continued to use hypoallergenic topical moisturizers.  On 1/6/10, the skin overnight become markedly red, taut, shiny, with involvement palms and soles. The rash was entirely confluent up to his lower jaw/earlobes. Above that, he had some pink and peeling skin. At this time, he was sent to Urgent Care where he had lab testing that later revealed elevated ASO titer 380, normal C3 118 and elevated C4 of 54. A throat culture came back negative, there was never a clinical appearance related to strep throat. There was suspicion for  Group A strep colonization/"scalded skin syndrome" causing his skin changes and he was put on a 14 day course of oral penicillin which has been completed at time of discharge. Refer to notes by authors (name removed) PA-C and (name removed), PA-C for additional information. On his skin, there were never any bullae/blisters/fissures. Within several days, profuse peeling of skin began over his entire body, including genitals. He did develop some superficial excoriations on posterior calves from scratching. These were healing well at time of discharge and peeling was almost gone.
pt recv vax 13AUG96 & w/in 1 to 2 hr pt exp swelling of the rt eyelid, hives around mouth & redness of both ears;pt was sleepy but easily aroused;tx w/DPH;MD uncertain if pt exp was r/t vax but is convinced that pt had an allerg rxn;
The pharmacist stated that, the patient did experience an unspecified HPV infection post vaccination; manufacturer origin unknown; This spontaneous report was received from a pharmacist concerning a 34 year old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies.     On an unknown date, also reported as (unspecified time in the past patient age was near 20 to 25 years old or so), the pharmacist stated that, the patient had previously completed a vaccination series for human papilloma virus (HPV) (dosage schedule, anatomical location, lot number and expiration date were not reported). That manufacturer was unknown (product origin unknown). On an unspecified date, the patient experienced an unspecified HPV infection post vaccination (papilloma viral infection). The vaccine may not have had protection against the strain the vaccine had.   The outcome of the events papilloma viral infection and product origin unknown and the causal relationship between the events and therapy with HPV vaccine were not reported.
No reported adverse events. Patient was 17 at the time. She was 8 months below the age Janssen vaccine was indicated for according to the EUA. There was confusion during the sign in process and the patient was initially thought to be 18 at the time.
Received Fluzone to left upper arm 10/11/07. Patient noticed that vaccine had been given more anterior upper arm.  10/12/07 developed sorness, redness and warm to touch injection site. 10/13-10/15/07 develped more redness, swelling, itching and overall muscle aches and shooting pains down legs. 10/16/07 seen Employee Health given Benadryl for itching, redness of upper arm 5-6 Inch diameter noted. Generalized itching, not feeling well, headache, weak,  not feeling well. Still have overall muscle aches.  (Has taken flu vaccine in the past) 10/18/07 Employee returned to facility and was given RX for Keflex. Cellulitis left arm.  Swollen lymph nodes left axillary area. Muscle aches all over esp. shoulder, neck, headache. 10/19-10/21/07 Symptoms continued as above except redness of arm and swelling decreased. 10/22/07 Seen muscle aches all over still, "I feel terrible all over" 10/25/07-10/29/07 Same symptoms overall muscle aches, only able to go to work then stayed in bed over the weekend. 10/30/07 Called out of work 10/30/07 felt to ill to work. 10/31/07 Thru 11-05-07 Increase in stiffness and muscle aches, especially in legs, having sharp pains while sitting in legs. Pain scale 10/10 during this time.  Visit 11/06/07 labs drawn *See Below* Employee temp 99.9 orally. Employee to see Primary physician appt 11/07/07. Labs drawn *See below*  Employee's Supervisor allowed her to take medical leave 11/07/07 thru 11/16/07.  11/19/07 9:30 am left message National Vaccine Injury Compensation PRogram 1-800-338-2382 concerning employee symptoms following flu vaccine. 12/11/07 11:45 am spoke with employee at work. Still have generalized muscle aches and feeling tired. Can barely make it through her work day then goes home and rests for the next day. Pain scale now is somewhat improved 5/10. Dr referred patient to Rheumatologist on 01/16/08 for eval and treatment and to determine relation to pain and flu vaccine.
I have been experiencing chronic head-to-toe hives for the past year.  Hives started two weeks after my second Moderna booster.
2 weeks after 2nd shot was awakened with terrible ringing  in left ear, went to primary care doctor was sent for hearing test, was sent to ENT doctor then to audiology, have appoint with massage therapist Fri, the 20th of August, now taking xanax for anxiety
Brain fog; Tired; booster dose; This is a spontaneous report received from a contactable Consumer via COVID-19 Adverse Event Self-Reporting Solution. The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Nov2021 12:00 (Batch/Lot number: unknown) at the age of 57 years as dose 3 (booster dose), single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left, Vaccine Administration Time: 12:15 PM), administration date: 30Mar2021, when the patient was 57 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Leg Left, Vaccine Administration Time: 12:30 PM), administration date: 09Mar2021, when the patient was 57 years old, for COVID-19 immunization.  The following information was reported: IMMUNISATION (non-serious) with onset 03Nov2021 12:00, outcome "unknown", described as "booster dose"; FEELING ABNORMAL (non-serious) with onset 05Nov2021, outcome "not recovered", described as "Brain fog"; FATIGUE (non-serious) with onset 05Nov2021, outcome "not recovered", described as "Tired". Therapeutic measures were not taken as a result of feeling abnormal, fatigue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.